FOLD logo

Amicus Therapeutics (FOLD) Shareholders Equity

Annual Shareholders Equity

$160.17 M
+$37.13 M+30.17%

December 31, 2023

Summary

Performance

1-Year Change

+30.17%

3-Year Change

-44.07%

5-Year Change

-53.29%

15-Year Change

-54.61%

FOLD Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

65.27%
FOLD annual stockholders equity is higher than 65.27% of companies in Healthcare sector

High & Low

All-time High

$476.43 M
FOLD annual stockholders equity is currently -66.38% below its historical high of $476.43 million

3-Year Low

$123.05 M
FOLD annual stockholders equity is currently +30.17% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
FOLD previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
FOLD next annual earnings announcement is scheduled for Feb 28, 2025

OtherFOLDbalance sheetmetrics:

Annual Retained Earnings

-$2.68 B
FOLD annual retained earnings is -$2.68 billion

Annual Working Capital

$315.37 M
FOLD annual working capital is $315.37 million

Annual Total Assets

$777.88 M
FOLD annual total assets is $777.88 million

Annual Total Liabilities

$617.71 M
FOLD annual total liabilities is $617.71 million

Quarterly Shareholders Equity

$178.82 M
+$46.30 M+34.94%

September 30, 2024

Summary

Performance

3-Month Change

+34.94%

1-Year Change

+34.22%

3-Year Change

+34.22%

5-Year Change

+34.22%

FOLD Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

65.78%
FOLD quarterly stockholders equity is higher than 65.78% of companies in Healthcare sector

High & Low

All-time High

$600.06 M
FOLD quarterly stockholders equity is currently -70.20% below its historical high of $600.06 million

3-Year Low

$102.57 M
FOLD quarterly stockholders equity is currently +74.34% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
FOLD previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
FOLD next earnings announcement is scheduled for Feb 28, 2025

OtherFOLDbalance sheetmetrics:

Quarterly Retained Earnings

-$2.75 B
FOLD quarterly retained earnings is -$2.75 billion

Quarterly Working Capital

$340.34 M
FOLD quarterly working capital is $340.34 million

Quarterly Total Assets

$786.56 M
FOLD quarterly total assets is $786.56 million

Quarterly Total Liabilities

$607.73 M
FOLD quarterly total liabilities is $607.73 million

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

Annual Shareholders Equity

$160.17 M
FOLD annual stockholders equity is $160.17 million

Annual Total Assets

$777.88 M
FOLD annual total assets is $777.88 million

Annual Total Liabilities

$617.71 M
FOLD annual total liabilities is $617.71 million

FOLD Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+30.2%+34.2%
3 y3 years-44.1%+34.2%
5 y5 years-53.3%+34.2%

FOLD Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-47.9%+30.2%-41.8%+74.3%
5 y5-year-66.4%+30.2%-62.5%+74.3%
alltimeall time-66.4%+306.6%-70.2%+307.3%

Amicus Therapeutics Shareholders Equity History

DateAnnualQuarterly
Sep 2024
-
$178.82 M(+34.9%)
Jun 2024
-
$132.52 M(+1.4%)
Mar 2024
-
$130.69 M(-18.4%)
Dec 2023
$160.17 M(+30.2%)
$160.17 M(+20.2%)
Sep 2023
-
$133.24 M(+19.4%)
Jun 2023
-
$111.58 M(+8.8%)
Mar 2023
-
$102.57 M(-16.6%)
Dec 2022
$123.05 M(-60.0%)
$123.05 M(-7.2%)
Sep 2022
-
$132.56 M(-23.6%)
Jun 2022
-
$173.43 M(-27.3%)
Mar 2022
-
$238.62 M(-22.4%)
Dec 2021
$307.37 M(+7.3%)
$307.37 M(-18.4%)
Sep 2021
-
$376.63 M(+76.1%)
Jun 2021
-
$213.91 M(-14.7%)
Mar 2021
-
$250.90 M(-12.4%)
Dec 2020
$286.38 M(-39.9%)
$286.38 M(-10.6%)
Sep 2020
-
$320.27 M(-11.3%)
Jun 2020
-
$360.95 M(-10.3%)
Mar 2020
-
$402.59 M(-15.5%)
Dec 2019
$476.43 M(+38.9%)
$476.43 M(-13.1%)
Sep 2019
-
$548.27 M(-8.6%)
Jun 2019
-
$600.06 M(+32.9%)
Mar 2019
-
$451.67 M(+31.7%)
Dec 2018
$342.91 M(-2.8%)
$342.91 M(-16.6%)
Sep 2018
-
$410.95 M(-26.9%)
Jun 2018
-
$561.89 M(+7.7%)
Mar 2018
-
$521.62 M(+47.8%)
Dec 2017
$352.85 M(-2.0%)
$352.85 M(-13.9%)
Sep 2017
-
$409.68 M(+53.5%)
Jun 2017
-
$266.89 M(-14.1%)
Mar 2017
-
$310.78 M(-13.7%)
Dec 2016
$360.15 M(+3.5%)
$360.15 M(+7.0%)
Sep 2016
-
$336.56 M(+0.7%)
Jun 2016
-
$334.24 M(+7.3%)
Mar 2016
-
$311.63 M(-10.4%)
Dec 2015
$347.83 M
$347.83 M(-8.2%)
Sep 2015
-
$378.75 M(+15.2%)
DateAnnualQuarterly
Jun 2015
-
$328.90 M(+216.2%)
Mar 2015
-
$104.01 M(-14.9%)
Dec 2014
$122.18 M(+167.0%)
$122.18 M(+182.3%)
Sep 2014
-
$43.28 M(+19.2%)
Jun 2014
-
$36.31 M(+16.8%)
Mar 2014
-
$31.08 M(-32.1%)
Dec 2013
$45.75 M(-33.9%)
$45.75 M(+72.7%)
Sep 2013
-
$26.49 M(-33.0%)
Jun 2013
-
$39.56 M(-25.8%)
Mar 2013
-
$53.34 M(-22.9%)
Dec 2012
$69.22 M(+133.9%)
$69.22 M(-9.8%)
Sep 2012
-
$76.76 M(+4.9%)
Jun 2012
-
$73.17 M(-9.4%)
Mar 2012
-
$80.78 M(+173.0%)
Dec 2011
$29.59 M(-54.4%)
$29.59 M(-19.6%)
Sep 2011
-
$36.79 M(-17.5%)
Jun 2011
-
$44.61 M(-15.9%)
Mar 2011
-
$53.06 M(-18.3%)
Dec 2010
$64.93 M(-9.6%)
$64.93 M(+28.6%)
Sep 2010
-
$50.49 M(-21.6%)
Jun 2010
-
$64.36 M(-13.3%)
Mar 2010
-
$74.19 M(+3.3%)
Dec 2009
$71.83 M(+1.1%)
$71.83 M(+93.3%)
Sep 2009
-
$37.16 M(-23.6%)
Jun 2009
-
$48.64 M(-19.3%)
Mar 2009
-
$60.26 M(-15.2%)
Dec 2008
$71.04 M(-31.2%)
$71.04 M(-14.4%)
Sep 2008
-
$83.02 M(-7.4%)
Jun 2008
-
$89.67 M(-8.2%)
Mar 2008
-
$97.69 M(-5.4%)
Dec 2007
$103.30 M(-233.3%)
$103.30 M(-9.1%)
Sep 2007
-
$113.69 M(-7.3%)
Jun 2007
-
$122.67 M(-242.2%)
Mar 2007
-
-$86.28 M(+11.3%)
Dec 2006
-$77.52 M(+116.3%)
-$77.52 M(+116.3%)
Dec 2005
-$35.83 M(+579.2%)
-$35.83 M
Dec 2003
-$5.28 M
-

FAQ

  • What is Amicus Therapeutics annual stockholders equity?
  • What is the all time high annual shareholders equity for Amicus Therapeutics?
  • What is Amicus Therapeutics annual shareholders equity year-on-year change?
  • What is Amicus Therapeutics quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Amicus Therapeutics?
  • What is Amicus Therapeutics quarterly shareholders equity year-on-year change?

What is Amicus Therapeutics annual stockholders equity?

The current annual shareholders equity of FOLD is $160.17 M

What is the all time high annual shareholders equity for Amicus Therapeutics?

Amicus Therapeutics all-time high annual stockholders equity is $476.43 M

What is Amicus Therapeutics annual shareholders equity year-on-year change?

Over the past year, FOLD annual stockholders equity has changed by +$37.13 M (+30.17%)

What is Amicus Therapeutics quarterly stockholders equity?

The current quarterly shareholders equity of FOLD is $178.82 M

What is the all time high quarterly shareholders equity for Amicus Therapeutics?

Amicus Therapeutics all-time high quarterly stockholders equity is $600.06 M

What is Amicus Therapeutics quarterly shareholders equity year-on-year change?

Over the past year, FOLD quarterly stockholders equity has changed by +$45.59 M (+34.22%)